Nova Eye USA Sales Growth Opportunity
Strong Existing Clinical Data Set Underpins Surgeon Adoption ne
Recent Peer Review Data
Publication
Consistency in Standalone Canaloplasty
Outcomes Using the iTrack Microcatheter
Authors
Journal
Khaimi, M (USA,
Gallardo M (USA)
and Korber N
(Germany).
Clinical
Ophthalmology,
2024.
Clinical outcomes of canaloplasty via an ab-
interno surgical technique using the iTrack
device: a narrative review
6-Year Efficacy and Safety of iTrack Ab-
interno Canaloplasty as a Standalone
Procedure and Combined
with Cataract Surgery in Primary Open-
Angle and Pseudoexfoliative Glaucoma
Long-Term Clinical and Safety Outcomes of
Canaloplasty Performed across All Grades
of Glaucoma Severity
Surgical Management of Intraocular
Pressure With Ab-interno Canaloplasty in
Postkeratoplasty Patients:
12-Month Results
Koerber N
(Germany), Ondrejka
S (Germany).
Koerber N
(Germany), Ondrejka
S (Germany).
International
Ophthalmology,
.
2023.
Journal of
Ophthalmology,
2023.
Journal of
Ophthalmology,
Patel S (USA),
Reiss G (USA).
2023.
.
•
•
•
Riaz KM et al (USA).
Cornea, 2023.
•
Data Overview
Multicenter, multi-surgeon, retrospective review of a consecutive case series
At 12 months, IOP (mmHg) was reduced in 57 of the 58 (98%) remaining eyes; one eye
had the same IOP with a reduced number of medications.
Nine studies which totalled 365 eyes.
At 12 and 24 months, IOP (mmHg) decreased from 20.0±2.5 preoperatively to 13.8±0.6
and 14.0±0.9.
Single-center retrospective case series of patients (n=27 eyes) followed for up to 6
years.
The mean IOP was reduced significantly from 19.9±5.2 mmHg (n=27) at baseline (no
washout) to 14.6±3.3 mmHg at the 6-year follow-up (n=18; p<0.001).
Single-center, retrospective case series study of glaucoma eyes (n=72) with mild-
moderate glaucoma as compared to severe glaucoma.
The mean preoperative IOP for the 72 eyes was 18.6±5.8 mmHg, which showed a 25%
reduction to 13.5±4.7 mmHg at 36 months (p<0.001).
Single-center, retrospective case series of postkeratoplasty eyes(n=17) undergoing ab-
interno canaloplasty (ABIC).
ABIC effectively reduced IOP and maintained graft survivability in postkeratoplasty
eyes for at least 12 months.
nova-eye.com | 18View entire presentation